• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性缺血性卒中中驱动医生模式以改善区域卒中护理网络:一项成本效益分析。

Drive-the-doctor paradigm in acute ischaemic stroke for improving regional stroke care networks: a cost-effectiveness analysis.

作者信息

Nguyen Chi Phuong, Uyttenboogaart Maarten, Maas Willemijn J, Buskens Erik, Lahr Maarten M H, van der Zee Durk-Jouke

机构信息

Department of Operations, Faculty of Economics and Business, University of Groningen, Groningen, The Netherlands

Health Technology Assessment, Department of Epidemiology, University Medical Center Groningen, Groningen, The Netherlands.

出版信息

BMJ Open. 2025 Mar 29;15(3):e091413. doi: 10.1136/bmjopen-2024-091413.

DOI:10.1136/bmjopen-2024-091413
PMID:40157729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11956349/
Abstract

BACKGROUND AND OBJECTIVE

In a drive-the-doctor (DD) paradigm, an interventionalist travels from a comprehensive stroke centre (CSC) to primary stroke centres (PSCs) to perform endovascular thrombectomy (EVT) for acute ischaemic stroke due to large vessel occlusion (LVO). The DD paradigm may reduce time delays from onset to recanalisation. This study aimed to analyse the cost-effectiveness of the DD paradigm versus a drip-and-ship (DS) paradigm, where LVO patients are transferred from PSCs to a CSC for EVT in the northern Netherlands.

DESIGN

Economic evaluation was performed using a simulation model combined with a decision tree and a Markov model.

SETTING

Stroke centres in the northern Netherlands.

PARTICIPANTS

A hypothetical cohort of 100 000 LVO patients with an average age of 70 years.

INTERVENTIONS

Two strategies were tested, including the DD paradigm with one upgraded PSC and the DD paradigm with two upgraded PSCs.

MAIN OUTCOME MEASURES

Total costs and quality-adjusted life years (QALYs) were measured over a 15-year time horizon from a Dutch healthcare provider perspective. An incremental cost-effectiveness ratio (ICER) of €50 000 was used as a willingness-to-pay threshold. One-way sensitivity, probabilistic sensitivity and scenario analyses (interventionalist transportation by car, ambulance and helicopter) were conducted to examine parameter uncertainty.

RESULTS

The DD paradigm using car as a transport modality and two PSCs was the optimal strategy, resulting in the lowest ICER. This strategy provided an additional 0.13 QALYs at incremental costs of €2367, yielding an ICER of €18 306 compared with current practice. The DD paradigm with two PSCs reduced ICERs compared with the scenario with one PSC when varying transportation modalities (car, ambulance and helicopter). Probabilistic sensitivity analyses showed that the DD paradigm with two PSCs using car was preferred in 72% of 10 000 Monte Carlo simulations.

CONCLUSIONS

The DD paradigm appeared cost-effective for LVO patients and may be considered a promising evolution for a regional stroke network.

摘要

背景与目的

在“驱动医生上门”(DD)模式中,介入专家从综合卒中中心(CSC)前往初级卒中中心(PSC),为因大血管闭塞(LVO)导致的急性缺血性卒中患者进行血管内血栓切除术(EVT)。DD模式可能会减少从发病到再通的时间延迟。本研究旨在分析DD模式与“点滴转运”(DS)模式的成本效益,在荷兰北部,LVO患者从PSC被转运至CSC进行EVT。

设计

采用结合决策树和马尔可夫模型的模拟模型进行经济评估。

地点

荷兰北部的卒中中心。

参与者

假设的100000名平均年龄为70岁的LVO患者队列。

干预措施

测试了两种策略,包括配备一个升级PSC的DD模式和配备两个升级PSC的DD模式。

主要结局指标

从荷兰医疗服务提供者的角度,在15年的时间范围内测量总成本和质量调整生命年(QALY)。以50000欧元的增量成本效益比(ICER)作为支付意愿阈值。进行单向敏感性分析、概率敏感性分析和情景分析(介入专家乘坐汽车、救护车和直升机运输)以检验参数不确定性。

结果

使用汽车作为运输方式且配备两个PSC的DD模式是最优策略,产生的ICER最低。与当前实践相比,该策略以2367欧元的增量成本提供了额外的0.13个QALY,ICER为18306欧元。当改变运输方式(汽车、救护车和直升机)时,配备两个PSC的DD模式与配备一个PSC的情景相比降低了ICER。概率敏感性分析表明,在10000次蒙特卡洛模拟中,72%的模拟结果显示使用汽车的配备两个PSC的DD模式更优。

结论

DD模式对LVO患者似乎具有成本效益,可能被视为区域卒中网络的一个有前景的发展方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebfd/11956349/ba58d274b765/bmjopen-15-3-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebfd/11956349/e9890c3daf84/bmjopen-15-3-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebfd/11956349/ba58d274b765/bmjopen-15-3-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebfd/11956349/e9890c3daf84/bmjopen-15-3-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebfd/11956349/ba58d274b765/bmjopen-15-3-g002.jpg

相似文献

1
Drive-the-doctor paradigm in acute ischaemic stroke for improving regional stroke care networks: a cost-effectiveness analysis.急性缺血性卒中中驱动医生模式以改善区域卒中护理网络:一项成本效益分析。
BMJ Open. 2025 Mar 29;15(3):e091413. doi: 10.1136/bmjopen-2024-091413.
2
Endovascular Thrombectomy Alone for Large Vessel Occlusion: A Cost-Effectiveness Evaluation Based on Meta-Analyses.单纯血管内血栓切除术治疗大血管闭塞:基于荟萃分析的成本效益评估。
Stroke. 2024 Oct;55(10):2482-2491. doi: 10.1161/STROKEAHA.124.047276. Epub 2024 Aug 12.
3
'Drive the doctor' for endovascular thrombectomy in a rural area: a simulation study.农村地区血管内血栓切除术的“推动医生”:一项模拟研究。
BMC Health Serv Res. 2023 Jul 20;23(1):778. doi: 10.1186/s12913-023-09672-5.
4
Costs and health effects of CT perfusion-based selection for endovascular thrombectomy within 6 hours of stroke onset: a model-based health economic evaluation.基于 CT 灌注的血管内血栓切除术在卒中发病后 6 小时内的选择的成本和健康效果:基于模型的健康经济学评价。
J Neurol Neurosurg Psychiatry. 2024 May 14;95(6):515-527. doi: 10.1136/jnnp-2023-331862.
5
Cost-effectiveness of endovascular treatment after 6-24 h in ischaemic stroke patients with collateral flow on CT-angiography: A model-based economic evaluation of the MR CLEAN-LATE trial.基于 CT 血管造影评估侧支循环的缺血性脑卒中患者发病 6-24 小时后血管内治疗的成本效果:MR CLEAN-LATE 试验的基于模型的经济学评价。
Eur Stroke J. 2024 Jun;9(2):348-355. doi: 10.1177/23969873231220464. Epub 2023 Dec 28.
6
Cost-effectiveness of remote robotic mechanical thrombectomy in acute ischemic stroke.急性缺血性卒中远程机器人机械取栓术的成本效益
J Neurosurg. 2023 Jan 20;139(3):721-731. doi: 10.3171/2022.12.JNS222115. Print 2023 Sep 1.
7
Lifetime quality of life and cost consequences of delays in endovascular treatment for acute ischaemic stroke: a cost-effectiveness analysis from a Singapore healthcare perspective.急性缺血性卒中血管内治疗延迟对终身生活质量和成本的影响:从新加坡医疗保健角度进行的成本效益分析。
BMJ Open. 2020 Sep 17;10(9):e036517. doi: 10.1136/bmjopen-2019-036517.
8
The economic impact associated with stent retriever selection for the treatment of acute ischemic stroke: a cost-effectiveness analysis of MASTRO I data from a Chinese healthcare system perspective.支架取栓术选择治疗急性缺血性脑卒中的经济影响:基于中国医疗体系视角下 MASTRO I 数据的成本效果分析。
J Comp Eff Res. 2024 Nov;13(11):e240160. doi: 10.57264/cer-2024-0160. Epub 2024 Nov 5.
9
Effect of "drip-and-ship" and "drip-and-drive" on endovascular treatment of acute ischemic stroke with large vessel occlusion: a single-center retrospective study.“点滴转运”和“点滴自驾”对大血管闭塞性急性缺血性卒中血管内治疗的影响:一项单中心回顾性研究。
Acta Radiol. 2022 May;63(5):658-663. doi: 10.1177/02841851211006897. Epub 2021 Apr 7.
10
Cost-effectiveness of Direct Transfer to Angiography Suite of Patients With Suspected Large Vessel Occlusion.疑似大血管闭塞患者直接转入血管造影室的成本效益。
Neurology. 2023 Sep 5;101(10):e1036-e1045. doi: 10.1212/WNL.0000000000207583. Epub 2023 Jul 12.

本文引用的文献

1
Cost-effectiveness of tenecteplase versus alteplase for acute ischemic stroke.替奈普酶与阿替普酶治疗急性缺血性脑卒中的成本效果分析。
Eur Stroke J. 2023 Sep;8(3):638-646. doi: 10.1177/23969873231174943. Epub 2023 May 19.
2
'Drive the doctor' for endovascular thrombectomy in a rural area: a simulation study.农村地区血管内血栓切除术的“推动医生”:一项模拟研究。
BMC Health Serv Res. 2023 Jul 20;23(1):778. doi: 10.1186/s12913-023-09672-5.
3
Cost-effectiveness of Direct Transfer to Angiography Suite of Patients With Suspected Large Vessel Occlusion.
疑似大血管闭塞患者直接转入血管造影室的成本效益。
Neurology. 2023 Sep 5;101(10):e1036-e1045. doi: 10.1212/WNL.0000000000207583. Epub 2023 Jul 12.
4
Clinical outcome, recanalization success, and time metrics in drip-and-ship vs. drive-the-doctor: A retrospective analysis of the HEI-LU-Stroke registry.静脉溶栓转运与医生随车转运的临床结局、再通成功率及时间指标:HEI-LU-卒中登记研究的回顾性分析
Front Neurol. 2023 Mar 9;14:1142983. doi: 10.3389/fneur.2023.1142983. eCollection 2023.
5
Annual Case Volume and One-Year Mortality for Endovascular Treatment in Acute Ischemic Stroke.急性缺血性脑卒中血管内治疗的年病例量和一年死亡率。
J Korean Med Sci. 2022 Sep 19;37(36):e270. doi: 10.3346/jkms.2022.37.e270.
6
Estimating the Burden of Stroke: Two-Year Societal Costs and Generic Health-Related Quality of Life of the Restore4Stroke Cohort.估算卒中负担:Restore4Stroke 队列的两年社会成本和通用健康相关生活质量。
Int J Environ Res Public Health. 2022 Sep 5;19(17):11110. doi: 10.3390/ijerph191711110.
7
Influences of different referral modes on clinical outcomes after endovascular therapy for acute ischemic stroke.不同转诊模式对急性缺血性脑卒中血管内治疗后临床结局的影响。
BMC Neurol. 2022 Jun 21;22(1):228. doi: 10.1186/s12883-022-02751-w.
8
Association Between Use of a Flying Intervention Team vs Patient Interhospital Transfer and Time to Endovascular Thrombectomy Among Patients With Acute Ischemic Stroke in Nonurban Germany.在非城市德国的急性缺血性脑卒中患者中,使用飞行干预团队与患者院间转运对血管内血栓切除术时间的影响。
JAMA. 2022 May 10;327(18):1795-1805. doi: 10.1001/jama.2022.5948.
9
Expediting workflow in the acute stroke pathway for endovascular thrombectomy in the northern Netherlands: a simulation model.荷兰北部急性卒中血管内血栓切除术路径中的工作流程加速:一个模拟模型
BMJ Open. 2022 Apr 6;12(4):e056415. doi: 10.1136/bmjopen-2021-056415.
10
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force.《健康经济评估报告标准(CHEERS)》2022 年解释与详述:ISPOR CHEERS II 良好实践工作组报告。
Value Health. 2022 Jan;25(1):10-31. doi: 10.1016/j.jval.2021.10.008.